 | • レポートコード：GIR-2104Z05227 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エリスロポエチン製剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エリスロポエチン製剤の種類別市場規模（エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他）、用途別市場規模（貧血、腎障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エリスロポエチン製剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他 ・用途別分析2016年-2026年：貧血、腎障害、その他 ・エリスロポエチン製剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エリスロポエチン製剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エリスロポエチン製剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エリスロポエチン製剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エリスロポエチン製剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Erythropoietin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Erythropoietin Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Erythropoietin Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Erythropoietin Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Market segment by Application can be divided into
Anemia
Kidney Disorders
Other
The key market players for global Erythropoietin Drugs market are listed below:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Erythropoietin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Erythropoietin Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.2.4 Epoetin-beta
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Erythropoietin Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Other
1.4 Global Erythropoietin Drugs Market Size & Forecast
1.4.1 Global Erythropoietin Drugs Sales in Value (2016-2026))
1.4.2 Global Erythropoietin Drugs Sales in Volume (2016-2026)
1.4.3 Global Erythropoietin Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Erythropoietin Drugs Production Capacity Analysis
1.5.1 Global Erythropoietin Drugs Total Production Capacity (2016-2026)
1.5.2 Global Erythropoietin Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Erythropoietin Drugs Market Drivers
1.6.2 Erythropoietin Drugs Market Restraints
1.6.3 Erythropoietin Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Erythropoietin Drugs Product and Services
2.1.4 Amgen Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Erythropoietin Drugs Product and Services
2.2.4 Johnson & Johnson Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Erythropoietin Drugs Product and Services
2.3.4 Roche Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Galenica
2.4.1 Galenica Details
2.4.2 Galenica Major Business
2.4.3 Galenica Erythropoietin Drugs Product and Services
2.4.4 Galenica Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Emcure
2.5.1 Emcure Details
2.5.2 Emcure Major Business
2.5.3 Emcure Erythropoietin Drugs Product and Services
2.5.4 Emcure Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Kyowa Hakko Kirin
2.6.1 Kyowa Hakko Kirin Details
2.6.2 Kyowa Hakko Kirin Major Business
2.6.3 Kyowa Hakko Kirin Erythropoietin Drugs Product and Services
2.6.4 Kyowa Hakko Kirin Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 3SBio
2.7.1 3SBio Details
2.7.2 3SBio Major Business
2.7.3 3SBio Erythropoietin Drugs Product and Services
2.7.4 3SBio Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business
2.8.3 Biocon Erythropoietin Drugs Product and Services
2.8.4 Biocon Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 LG Life Sciences
2.9.1 LG Life Sciences Details
2.9.2 LG Life Sciences Major Business
2.9.3 LG Life Sciences Erythropoietin Drugs Product and Services
2.9.4 LG Life Sciences Erythropoietin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Erythropoietin Drugs Sales by Manufacturer
3.1 Global Erythropoietin Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Erythropoietin Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Erythropoietin Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Erythropoietin Drugs Manufacturer Market Share
3.4.2 Top 6 Erythropoietin Drugs Manufacturer Market Share
3.5 Global Erythropoietin Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Erythropoietin Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Erythropoietin Drugs Market Size by Region
4.1.1 Global Erythropoietin Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Erythropoietin Drugs Revenue by Region (2016-2026)
4.2 North America Erythropoietin Drugs Revenue (2016-2026)
4.3 Europe Erythropoietin Drugs Revenue (2016-2026)
4.4 Asia-Pacific Erythropoietin Drugs Revenue (2016-2026)
4.5 South America Erythropoietin Drugs Revenue (2016-2026)
4.6 Middle East and Africa Erythropoietin Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Erythropoietin Drugs Sales in Volume by Type (2016-2026)
5.2 Global Erythropoietin Drugs Revenue by Type (2016-2026)
5.3 Global Erythropoietin Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Erythropoietin Drugs Sales in Volume by Application (2016-2026)
6.2 Global Erythropoietin Drugs Revenue by Application (2016-2026)
6.3 Global Erythropoietin Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Erythropoietin Drugs Sales by Type (2016-2026)
7.2 North America Erythropoietin Drugs Sales by Application (2016-2026)
7.3 North America Erythropoietin Drugs Market Size by Country
7.3.1 North America Erythropoietin Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Erythropoietin Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Erythropoietin Drugs Sales by Type (2016-2026)
8.2 Europe Erythropoietin Drugs Sales by Application (2016-2026)
8.3 Europe Erythropoietin Drugs Market Size by Country
8.3.1 Europe Erythropoietin Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Erythropoietin Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Erythropoietin Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Erythropoietin Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Erythropoietin Drugs Market Size by Region
9.3.1 Asia-Pacific Erythropoietin Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Erythropoietin Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Erythropoietin Drugs Sales by Type (2016-2026)
10.2 South America Erythropoietin Drugs Sales by Application (2016-2026)
10.3 South America Erythropoietin Drugs Market Size by Country
10.3.1 South America Erythropoietin Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Erythropoietin Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Erythropoietin Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Erythropoietin Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Erythropoietin Drugs Market Size by Country
11.3.1 Middle East & Africa Erythropoietin Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Erythropoietin Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Erythropoietin Drugs Typical Distributors
12.3 Erythropoietin Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Erythropoietin Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Erythropoietin Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Erythropoietin Drugs Product and Services
Table 6. Amgen Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Erythropoietin Drugs Product and Services
Table 10. Johnson & Johnson Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Erythropoietin Drugs Product and Services
Table 14. Roche Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Galenica Basic Information, Manufacturing Base and Competitors
Table 16. Galenica Major Business
Table 17. Galenica Erythropoietin Drugs Product and Services
Table 18. Galenica Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Emcure Basic Information, Manufacturing Base and Competitors
Table 20. Emcure Major Business
Table 21. Emcure Erythropoietin Drugs Product and Services
Table 22. Emcure Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 24. Kyowa Hakko Kirin Major Business
Table 25. Kyowa Hakko Kirin Erythropoietin Drugs Product and Services
Table 26. Kyowa Hakko Kirin Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. 3SBio Basic Information, Manufacturing Base and Competitors
Table 28. 3SBio Major Business
Table 29. 3SBio Erythropoietin Drugs Product and Services
Table 30. 3SBio Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Biocon Basic Information, Manufacturing Base and Competitors
Table 32. Biocon Major Business
Table 33. Biocon Erythropoietin Drugs Product and Services
Table 34. Biocon Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 36. LG Life Sciences Major Business
Table 37. LG Life Sciences Erythropoietin Drugs Product and Services
Table 38. LG Life Sciences Erythropoietin Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Erythropoietin Drugs Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 40. Global Erythropoietin Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Erythropoietin Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Erythropoietin Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 43. Head Office and Erythropoietin Drugs Production Site of Key Manufacturer
Table 44. Global Erythropoietin Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 45. Global Erythropoietin Drugs Sales by Region (2021-2026) & (K Pcs)
Table 46. Global Erythropoietin Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Erythropoietin Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Erythropoietin Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 49. Global Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs)
Table 50. Global Erythropoietin Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Erythropoietin Drugs Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Erythropoietin Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 53. Global Erythropoietin Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 54. Global Erythropoietin Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 55. Global Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs)
Table 56. Global Erythropoietin Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Erythropoietin Drugs Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Erythropoietin Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 59. Global Erythropoietin Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 60. North America Erythropoietin Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 61. North America Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs)
Table 62. North America Erythropoietin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Erythropoietin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Erythropoietin Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 65. North America Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs)
Table 66. North America Erythropoietin Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 67. North America Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs)
Table 68. Europe Erythropoietin Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 69. Europe Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs)
Table 70. Europe Erythropoietin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Erythropoietin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Erythropoietin Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 73. Europe Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs)
Table 74. Europe Erythropoietin Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 75. Europe Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Erythropoietin Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 77. Asia-Pacific Erythropoietin Drugs Sales by Region (2021-2026) & (K Pcs)
Table 78. Asia-Pacific Erythropoietin Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Erythropoietin Drugs Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Erythropoietin Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs)
Table 82. Asia-Pacific Erythropoietin Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 83. Asia-Pacific Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs)
Table 84. South America Erythropoietin Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 85. South America Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs)
Table 86. South America Erythropoietin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Erythropoietin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Erythropoietin Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 89. South America Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs)
Table 90. South America Erythropoietin Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 91. South America Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Erythropoietin Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 93. Middle East & Africa Erythropoietin Drugs Sales by Country (2021-2026) & (K Pcs)
Table 94. Middle East & Africa Erythropoietin Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Erythropoietin Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Erythropoietin Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa Erythropoietin Drugs Sales by Type (2021-2026) & (K Pcs)
Table 98. Middle East & Africa Erythropoietin Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 99. Middle East & Africa Erythropoietin Drugs Sales by Application (2021-2026) & (K Pcs)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Erythropoietin Drugs Typical Distributors
Table 103. Erythropoietin Drugs Typical Customers
List of Figures
Figure 1. Erythropoietin Drugs Picture
Figure 2. Global Erythropoietin Drugs Sales Market Share by Type in 2020
Figure 3. Epoetin-alfa
Figure 4. Darbepoetin-alfa
Figure 5. Epoetin-beta
Figure 6. Others
Figure 7. Global Erythropoietin Drugs Sales Market Share by Application in 2020
Figure 8. Anemia
Figure 9. Kidney Disorders
Figure 10. Other
Figure 11. Global Erythropoietin Drugs Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 12. Global Erythropoietin Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Erythropoietin Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Erythropoietin Drugs Sales (2016-2026) & (K Pcs)
Figure 33. Global Erythropoietin Drugs Production Capacity (2016-2026) & (K Pcs)
Figure 34. Global Erythropoietin Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Erythropoietin Drugs Market Drivers
Figure 36. Erythropoietin Drugs Market Restraints
Figure 37. Erythropoietin Drugs Market Trends
Figure 38. Global Erythropoietin Drugs Sales Market Share by Manufacturer in 2020
Figure 39. Global Erythropoietin Drugs Revenue Market Share by Manufacturer in 2020
Figure 40. Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Erythropoietin Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Erythropoietin Drugs Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Erythropoietin Drugs Sales Market Share by Region (2016-2026)
Figure 44. Global Erythropoietin Drugs Revenue Market Share by Region (2016-2026)
Figure 45. North America Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Europe Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 48. South America Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Erythropoietin Drugs Revenue (2016-2026) & (USD Million)
Figure 50. Global Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 51. Global Erythropoietin Drugs Revenue Market Share by Type (2016-2026)
Figure 52. Global Erythropoietin Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 53. Global Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 54. Global Erythropoietin Drugs Revenue Market Share by Application (2016-2026)
Figure 55. Global Erythropoietin Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 56. North America Erythropoietin Drugs Sales Market Share by Country (2016-2026)
Figure 57. North America Erythropoietin Drugs Revenue Market Share by Country (2016-2026)
Figure 58. North America Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 59. North America Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 60. Europe Erythropoietin Drugs Sales Market Share by Country (2016-2026)
Figure 61. Europe Erythropoietin Drugs Revenue Market Share by Country (2016-2026)
Figure 62. Europe Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Erythropoietin Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Erythropoietin Drugs Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Erythropoietin Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 68. South America Erythropoietin Drugs Sales Market Share by Country (2016-2026)
Figure 69. South America Erythropoietin Drugs Revenue Market Share by Country (2016-2026)
Figure 70. South America Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 71. South America Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Erythropoietin Drugs Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Erythropoietin Drugs Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Erythropoietin Drugs Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Erythropoietin Drugs Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のエポエチン-アルファエリスロポエチン市場 2021：企業別、地域別、種類・用途別 The Epoetin-alfa Erythropoietin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- 世界のエポエチン-ベータエリスロポエチン市場 2021：企業別、地域別、種類・用途別 The Epoetin-beta Erythropoietin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界のエリスロポエチン刺激剤市場規模・現状・予測（2021年-2027年） Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. Market Analysis and Insights: Global Erythropoietin Stimulat…
- 世界の貧血治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anemia Drugs Market The global Anemia Drugs market size is projected to reach US$ 15910 million by 2026, from US$ 11620 million in 2019, at a CAGR of 4.5% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a br…
- 世界の骨髄増殖性疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Myeloproliferative Disorders Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…